Kwaku Dad Abu-Bonsrah

Dr. Kwaku Dad Abu-Bonsrah

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2021 in European Heart Journal
Verified
Journal Article
Open access
PDF file
LLLuis R Lopes
Luis R Lopes
SGSoledad Garcia-Hernández
Soledad Garcia-Hernández
MLMassimiliano Lorenzini
Massimiliano Lorenzini
MFMarta Futema
Marta Futema
Olga S. ChumakovaOlga S. Chumakova
Olga S. Chumakova
Perry ElliottPerry Elliott
Perry Elliott
The aim of this study was to determine the frequency of heterozygous truncating ALPK3 variants (ALPK3tv) in patients with hypertrophic cardiomyopathy (HCM) and confirm their pathogenicity using burden testing in independent cohorts and family co-segregation studies. In a discovery cohort of 770 index patients with HCM, 12 (1.56%) were heterozygous for ALPK3tv [odds ratio(OR) 16.11, 95% confidence interval (CI) 7.94–30.02, P = 8.05e−11] compared to the Genome Aggregation Database (gnomAD) population. In a validation cohort of 2047 HCM probands, 32 (1.56%) carried heterozygous ALPK3tv (OR 16.17, 95% CI 10.31–24.87, P < 2.2e−16, compared to gnomAD). Combined logarithm of odds score in seven families with ALPK3tv was 2.99. In comparison with a cohort of genotyped patients with HCM (n = 1679) with and without pathogenic sarcomere gene variants (SP+ and SP−), ALPK3tv carriers had a higher prevalence of apical/concentric patterns of hypertrophy (60%, P < 0.001) and of a short PR interval (10%, P = 0.009). Age at diagnosis and maximum left ventricular wall thickness were similar to SP− and left ventricular systolic impairment (6%) and non-sustained ventricular tachycardia (31%) at baseline similar to SP+. After 5.3 ± 5.7 years, 4 (9%) patients with ALPK3tv died of heart failure or had cardiac transplantation (log-rank P = 0.012 vs. SP− and P = 0.425 vs. SP+). Imaging and histopathology showed extensive myocardial fibrosis and myocyte vacuolation. Heterozygous ALPK3tv are pathogenic and segregate with a characteristic HCM phenotype. Truncating variants in ALPK3 are a cause of 1–2% of autosomal dominant hypertrophic cardiomyopathy and are associated with a phenotype characterized by extensive fibrosis and a predominantly concentric or apical pattern of left ventricular hypertrophy without left ventricular outflow tract obstruction. (A) Main phenotype characteristics and outcomes. ALPK3tv, alpha-protein kinase 3-truncating variants; CK, creatine kinase; HCM, hypertrophic cardiomyopathy; ICD, implantable cardioverter–defibrillator; LVH, left ventricular hypertrophy; LVSD, left ventricular systolic dysfunction; SCD, sudden cardiac death. (B) Cardiac magnetic resonance imaging showing the prevalent phenotype of severe mid to apical hypertrophy and extensive late gadolinium enhancement in three patients. Left to right: 4-chamber view end-diastole cine image, 4-chamber view late gadolinium enhancement image, short axis late gadolinium enhancement image. (C) Kaplan–Meier analysis comparing incidence of an outcome of heart failure death and transplant between ALP3tv patients, sarcomere positive and sarcomere negative. SARC+: sarcomere positive; SARC−: sarcomere negative.

13 March 2025 in The Neuroscientist
Verified
Journal Article
Open access
BKBrett Kagan
Brett Kagan
FHForough Habibollahi
Forough Habibollahi
BWBrad Watmuff
Brad Watmuff
AAAzin Azadi
Azin Azadi
FDFinn Doensen
Finn Doensen
NRNicole Kerlero de Rosbo
Nicole Kerlero de Rosbo
Harnessing intelligence from brain cells in vitro requires a multidisciplinary approach integrating wetware, hardware, and software. Wetware comprises the in vitro brain cells themselves, where differentiation from induced pluripotent stem cells offers ethical scalability; hardware typically involves a life support system and a setup to record the activity from and deliver stimulation to the brain cells; and software is required to control the hardware and process the signals coming from and going to the brain cells. This review provides a broad summary of the foundational technologies underpinning these components, along with outlining the importance of technology integration. Of particular importance is that this new technology offers the ability to extend beyond traditional methods that assess primarily the survival and spontaneous activity of neural cultures. Instead, the focus returns to the core function of neural tissue: the neurocomputational ability to process information and respond accordingly. Therefore, this review also covers work that, despite the relatively early state of current technology, has provided novel and meaningful understandings in the field of neuroscience along with opening exciting avenues for future research.

26 October 2021 in Cells
Verified
Journal Article
Open access
PDF file
KAKwaku Dad Abu-Bonsrah
Kwaku Dad Abu-Bonsrah
DNDonald F. Newgreen
Donald F. Newgreen
MDMirella Dottori
Mirella Dottori
Medullary thyroid carcinoma contributes to about 3–4% of thyroid cancers and affects C cells rather than follicular cells. Thyroid C cell differentiation from human pluripotent stem cells has not been reported. We report the stepwise differentiation of human embryonic stem cells into thyroid C cell-like cells through definitive endoderm and anterior foregut endoderm and ultimobranchial body-like intermediates in monolayer and 3D Matrigel culture conditions. The protocol involved sequential treatment with interferon/transferrin/selenium/pyruvate, foetal bovine serum, and activin A, then IGF-1 (Insulin-like growth factor 1), on the basis of embryonic thyroid developmental sequence. As well as expressing C cell lineage relative to follicular-lineage markers by qPCR (quantitative polymerase chain reaction) and immunolabelling, these cells by ELISA (enzyme-linked immunoassay) exhibited functional properties in vitro of calcitonin storage and release of calcitonin on calcium challenge. This method will contribute to developmental studies of the human thyroid gland and facilitate in vitro modelling of medullary thyroid carcinoma and provide a valuable platform for drug screening.

20 October 2025 in bioRxiv
Verified
Preprint
Open access
CWChangqing Wang
Changqing Wang
YPYair D.J. Prawer
Yair D.J. Prawer
OVOliver Voogd
Oliver Voogd
JSJakob Schuster
Jakob Schuster
CPCamilla Pasquali
Camilla Pasquali
YYYupei You
Yupei You
Long-read single-cell RNA-sequencing enables the profiling of RNA isoform expression and alternative splicing at single cell resolution. However, diverse single-cell technologies and sparse isoform data demand flexible and accurate analysis tools. We introduce FLAMESv2 , a highly modular and protocol-agnostic R/Bioconductor package for long-read single-cell RNA-seq data analysis. FLAMESv2 supports a wide range of single-cell and spatial protocols, is highly configurable, scales to allow multi-sample analysis and provides versatile visualisation and analysis outputs. We demonstrate its compatibility with both droplet-based and combinatorial barcoding single-cell methods, as well as spatial transcriptomics workflows. Benchmarking confirms FLAMESv2 achieves field-leading performance across key analysis tasks. Applying FLAMESv2 to in vitro differentiation of stem cells into neurons, we identify cell-types, differentiation trajectories, expression of annotated and novel isoforms and isoform expression diversity and heterogeneity within individual cells. FLAMESv2 provides a comprehensive, flexible approach to analysing long-read single-cell RNA-sequencing, unlocking this powerful methodology for RNA isoform characterisation.

1 August 2026 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
YLYan Li
Yan Li
MPMaximilian Powell
Maximilian Powell
JCJessica Chedid
Jessica Chedid
RSRatneswary Sutharsan
Ratneswary Sutharsan
ALAdahir Labrador-Garrido
Adahir Labrador-Garrido
GWGautam Wali
Gautam Wali
Mitochondrial and lysosomal dysfunction are central features of Parkinson’s disease (PD) across major genetic forms including PRKN , SNCA , and LRRK2 . We applied cell morphomics , a machine-learning-based framework combining high-content imaging with quantitative feature extraction, to analyse mitochondrial and lysosomal morphology at single-cell resolution in iPS cell-derived cortical neurons from PD patients and healthy controls (13 lines total). Supervised machine-learning models distinguished PD neurons from controls with high accuracy (AUC = 0.87) and reliably separated individual genotypes. Feature importance and attribution analysis revealed genotype-specific organelle biases in the relative contribution of mitochondrial and lysosomal features, with mitochondrial features dominating classification in PRKN neurons, balanced mitochondrial and lysosomal contributions in SNCA neurons, and a greater lysosomal contribution in LRRK2 neurons. Multi-class models retained strong performance, and findings were reproduced across two independent laboratories using different dyes and imaging conditions. These results demonstrate that morphomics provides a robust and scalable framework to quantify genotype-specific organelle abnormalities in PD neurons and supports its application for cellular stratification and biomarker discovery.

23 January 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
KAKwaku Dad Abu-Bonsrah
Kwaku Dad Abu-Bonsrah
CDCandice Desouza
Candice Desouza
HCHui Wen Chan
Hui Wen Chan
FHForough Habibollahi
Forough Habibollahi
BWBrad Watmuff
Brad Watmuff
BKBrett Kagan
Brett Kagan
The diverse computational functions of the human hippocampus rely on coordinated interactions among dentate gyrus (DG), CA3, and CA1 subfields, yet generating all three neuronal identities in vitro - particularly CA1 - has remained challenging. Here we establish a reproducible and modular differentiation protocol that directs human pluripotent stem cells through dorsomedial telencephalic progenitors to DG, CA3 and CA1 neurons and regionally specified hippocampal astrocytes. Early tri-inhibition with sonic hedgehog inhibition generated FOXG1+PAX6+ forebrain progenitors, while FGF2 treatment maintained the progenitors and induced TBR2+ intermediate progenitors, and controlled WNT activation with CHIR99021 enriched PROX1+ hippocampal progenitors in two donor lines. Bulk RNA-seq confirmed hippocampal identity, and a promoter-driven reporter for a CA1-specific gene [ MPPED1 ] validated CA1 neurons, alongside DG (PROX1), CA3 (ELAVL2, GRIK4, SCGN) and CA1 (WFS1, OCT6) markers and maturing synaptic puncta. Hippocampal organoids remained active for more than 400 days, with higher firing rates, information entropy and hub-like causal connectivity than monolayers; astrocyte-supplemented monolayers showed intermediate maturation. This platform enables systematic experimental control of neuron-astrocyte ratio, culture geometry and developmental timing for studying human hippocampal development, circuit function and disease.